Italia markets closed

AVIR Jul 2024 7.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,01000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0100
Aperto0,0100
Denaro0,0000
Domanda0,2500
Prezzo d'esercizio7,50
Scadenza2024-07-19
Min-Max giorno0,0100 - 0,0100
Contratto - Min-MaxN/D
Volume1
Open Interest162
  • GlobeNewswire

    Atea Pharmaceuticals to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that members of the Atea management team will participate in a fireside chat and present a business update at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023 at 10:10 a.m. ET. A live webcast of the pre

  • GlobeNewswire

    Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

    Enrollment continues in global Phase 3 SUNRISE-3 trial evaluating bemnifosbuvir for treatment of COVID-19Phase 3 SUNRISE-3 trial protocol amended to broaden eligibility criteria for high-risk patients and adapt to current COVID-19 environmentEnrollment continues in Phase 2 trial evaluating combination of bemnifosbuvir and ruzasvir for treatment of hepatitis C (HCV) with initial results expected in 4Q23Conference call at 4:30 pm ET today BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceutic

  • GlobeNewswire

    Atea Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023

    BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Tuesday, August 8, 2023, at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2023, and to provide a business update. To access the live conference call, pa